173 related articles for article (PubMed ID: 8359640)
21. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study.
Laakso S; Valta H; Verkasalo M; Toiviainen-Salo S; Mäkitie O
J Pediatr; 2014 Jun; 164(6):1436-43.e1. PubMed ID: 24650398
[TBL] [Abstract][Full Text] [Related]
22. Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study.
Calenda KA; Schornagel IL; Sadeghi-Nejad A; Grand RJ
Inflamm Bowel Dis; 2005 May; 11(5):435-41. PubMed ID: 15867582
[TBL] [Abstract][Full Text] [Related]
23. Linear growth following surgery in children and adolescents with Crohn's disease: relationship to pubertal status.
Alperstein G; Daum F; Fisher SE; Aiges H; Markowitz J; Becker J; So H; Schwartz D; Silverberg M; Schneider K
J Pediatr Surg; 1985 Apr; 20(2):129-33. PubMed ID: 4009358
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory bowel disease in children 5 years of age and younger.
Mamula P; Telega GW; Markowitz JE; Brown KA; Russo PA; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2002 Aug; 97(8):2005-10. PubMed ID: 12190168
[TBL] [Abstract][Full Text] [Related]
25. Growth failure in the child with inflammatory bowel disease.
Stephens M; Batres LA; Ng D; Baldassano R
Semin Gastrointest Dis; 2001 Oct; 12(4):253-62. PubMed ID: 11726079
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of Helicobacter pylori gastritis in newly diagnosed children with inflammatory bowel disease.
Roka K; Roubani A; Stefanaki K; Panayotou I; Roma E; Chouliaras G
Helicobacter; 2014 Oct; 19(5):400-5. PubMed ID: 24827117
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus.
Rygg M; Pistorio A; Ravelli A; Maghnie M; Di Iorgi N; Bader-Meunier B; Da Silva C; Roldan-Molina R; Barash J; Dracou C; Laloum SG; Jarosova K; Deslandre CJ; Koné-Paut I; Garofalo F; Press J; Sengler C; Tauber T; Martini A; Ruperto N;
Ann Rheum Dis; 2012 Apr; 71(4):511-7. PubMed ID: 21998114
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.
Nobile S; Grand RJ; Pappa HM
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):471-476. PubMed ID: 29438136
[TBL] [Abstract][Full Text] [Related]
29. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms.
Pfefferkorn M; Burke G; Griffiths A; Markowitz J; Rosh J; Mack D; Otley A; Kugathasan S; Evans J; Bousvaros A; Moyer MS; Wyllie R; Oliva-Hemker M; Carvalho R; Crandall W; Keljo D; Walters TD; LeLeiko N; Hyams J
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):168-74. PubMed ID: 19179878
[TBL] [Abstract][Full Text] [Related]
30. Systematic review: Body composition in children with inflammatory bowel disease.
Thangarajah D; Hyde MJ; Konteti VK; Santhakumaran S; Frost G; Fell JM
Aliment Pharmacol Ther; 2015 Jul; 42(2):142-57. PubMed ID: 26043941
[TBL] [Abstract][Full Text] [Related]
31. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
32. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
Haffner D; Schaefer F; Nissel R; Wühl E; Tönshoff B; Mehls O
N Engl J Med; 2000 Sep; 343(13):923-30. PubMed ID: 11006368
[TBL] [Abstract][Full Text] [Related]
33. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.
Murch SH; Lamkin VA; Savage MO; Walker-Smith JA; MacDonald TT
Gut; 1991 Aug; 32(8):913-7. PubMed ID: 1885073
[TBL] [Abstract][Full Text] [Related]
34. Bone Mass Development from Childhood into Young Adulthood in Patients with Childhood-onset Inflammatory Bowel Disease.
Sigurdsson GV; Schmidt S; Mellström D; Ohlsson C; Kindblom JM; Lorentzon M; Saalman R
Inflamm Bowel Dis; 2017 Dec; 23(12):2215-2226. PubMed ID: 29064856
[TBL] [Abstract][Full Text] [Related]
35. Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease.
Ezri J; Marques-Vidal P; Nydegger A
Digestion; 2012; 85(4):308-19. PubMed ID: 22688404
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory bowel disease and predisposition to osteopenia.
Cowan FJ; Warner JT; Dunstan FD; Evans WD; Gregory JW; Jenkins HR
Arch Dis Child; 1997 Apr; 76(4):325-9. PubMed ID: 9166024
[TBL] [Abstract][Full Text] [Related]
37. Nutrition and growth in inflammatory bowel disease.
Shamir R
World Rev Nutr Diet; 2013; 106():156-61. PubMed ID: 23428695
[TBL] [Abstract][Full Text] [Related]
38. Adiposity is associated with early reduction in bone mass in pediatric inflammatory bowel disease.
Setty-Shah N; Maranda L; Nwosu BU
Nutrition; 2016; 32(7-8):761-6. PubMed ID: 27138109
[TBL] [Abstract][Full Text] [Related]
39. Growth and growth hormone treatment in short stature children born small for gestational age.
Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density assessment in children with inflammatory bowel disease.
Gokhale R; Favus MJ; Karrison T; Sutton MM; Rich B; Kirschner BS
Gastroenterology; 1998 May; 114(5):902-11. PubMed ID: 9558278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
